This inventor holds 1 USPTO granted patent. Top assignee: Chisso Corporation. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: The Innovations of Fumitaka Ohizumi
Introduction
Fumitaka Ohizumi, an esteemed inventor from Chiba-ken, Japan, is known for his significant contributions to the field of chemistry, particularly in the production processes of pharmaceutical compounds. With a focus on efficiency, Ohizumi has developed innovative methods that enhance the production of crucial intermediates in drug synthesis.
Latest Patents
Fumitaka Ohizumi holds a notable patent titled "Process for Producing an Intermediate of a New Quinolone Compound." This innovative process offers a highly efficient method for synthesizing a key intermediate for the quinolone anti-fungal agent CP-99219. The method includes a complex sequence of seven steps, utilizing a cyclopropanetricarboxylic acid triester as a starting material. The resulting compound is characterized by specific substituents represented by formulas that detail the various alkyl and aryl groups.
Career Highlights
Throughout his career, Fumitaka Ohizumi has demonstrated a commitment to advancing pharmaceutical technology. Working with the Chisso Corporation, he has been at the forefront of research aimed at developing new medicines. His patent showcases not only his inventive spirit but also his ability to solve complex chemical challenges through innovative processes.
Collaborations
At Chisso Corporation, Fumitaka Ohizumi has had the pleasure of collaborating with talented coworkers, including Yasuo Urata and Mamoru Fujita. These collaborations have undoubtedly contributed to the successful development of his patented processes and further innovation within the company.
Conclusion
Fumitaka Ohizumi’s contributions to the field of pharmaceutical production are significant. His innovative approach and successful patent reflect not only his expertise but also his dedication to improving the efficiency of drug synthesis. As the industry continues to evolve, inventors like Ohizumi will play an essential role in advancing medical technology and improving healthcare outcomes globally.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile